Resource Center
Explore Resource Types
We have housed the technical documents (SDS, COAs, Manuals and more) in a dedicated section.
Explore all All Resources
Filters
Select resource types
Select products & services
Select solutions (2)
Active Filters (2)
Clear All
37 - 48 of 185 Results
Sort by:
Best Match

CRISPRa: Transcriptional upregulation screening with genome-wide CRISPR activation
This application note demonstrates transcriptional upregulation screening with genome-wide CRISPR activation.

The dual screen: Parallel genome-wide CRISPRi and CRISPRa screening
Discover the advantages of a dual screen using CRISPRi and CRISPRa screening in parallel in this application note.

CRISPRi: Transcriptional repression screening with genome-wide CRISPR interference
This application note demonstrates transcriptional regression screening with a novel whole-genome CRISPRi platform.

Preclinical services reading list
Selected publications that utilizes Revvity’s Preclinical Services to enhance scientific research and progress drug discovery.

Target essentiality assay
This application note demonstrates Revvity’s target essentiality assay which indicates whether or not a specific gene is essential for survival and/or proliferation in a given cell line.

How CRISPR-based functional genomics is transforming drug discovery
Exploring how functional genomics is used in preclinical drug discovery with target identification, drug response mechanisms, and in vivo tumor biology.

CHOSOURCE™ GS KO cell line: optimization, improvement strategy, and case study
On-demand webinar showing how to enhance bioprocess in CHO cell lines through molecular design, screening, and process optimization strategies, utilizing the CHOSOURCE expression platform.

Advancing biotherapeutic development with transposon-based technologies
Discover how to generate highly producing pools early on in your development workflow with transposon technology and accelerate time to clinic

CHOSOURCE ADCC+ cell line for enhanced therapeutic potency
Discover how the CHOSOURCE ADCC+ cell line increases Antibody Dependent Cellular Cytotoxicity (ADCC) for use in the production of biotherapeutics for oncology, anti-infectives and auto-immune diseases.

Application of gene editing technologies to improve biotherapeutic manufacturing
Showcasing a multiplex gene editing approach with well-defined workflows and established tools to isolate, identify, and characterize edited knock-out or knock-in clones in different cell types.

Integration of next-generation transposon vectors with state-of-the-art host cell lines
Presenting the performance data of CHOSOURCE TnT expressing a standard immunoglobulin G (IgG) molecule with CHOSOURCE CHO-K1 GS KO and ADCC+ cell lines

Webinar. Are you stable or transient? Optimize your biotherapeutic cell line workflows
Hear how Jounce integrated Revvity’s CHOSOURCE GS cell line into their drug development workflow to improve efficiencies


Looking for technical documents?
Find the technical documents you need, ASAP, in our easy-to-search library.